Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
False
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 2, 2026
5 min read
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies
November 2, 2026
2 min read
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
October 30, 2026
5 min read
Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.
October 29, 2026
9 min read
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
False
Affiliations:
Specialties:
Areas of Expertise: